Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.430
+0.130 (3.94%)
Apr 8, 2026, 12:06 PM EDT - Market open
Rezolute Market Cap
Rezolute has a market cap or net worth of $356.28 million as of April 8, 2026. Its market cap has increased by 93.00% in one year.
Market Cap
356.28M
Enterprise Value
211.13M
1-Year Change
93.00%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $356.28M, an increase of 113.34%. That is a compound annual growth rate of 15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 315.80M | 44.33% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 358.77M |
| Niagen Bioscience | 358.71M |
| Puma Biotechnology | 354.61M |
| DiaMedica Therapeutics | 352.93M |
| Opus Genetics | 350.05M |
| Cabaletta Bio | 341.76M |
| Bicycle Therapeutics | 341.56M |
| X4 Pharmaceuticals | 339.13M |